Processes of care and survival associated with treatment in specialist teenage and young adult cancer centres: results from the BRIGHTLIGHT cohort study

Objective Survival gains in teenagers and young adults (TYA) are reported to be lower than children and adults for some cancers. Place of care is implicated, influencing access to specialist TYA professionals and research. Consequently, age-appropriate specialist cancer care is advocated for TYA although systematic investigation of associated outcomes is lacking. In England, age-appropriate care is delivered through 13 Principal Treatment Centres (TYA-PTC). BRIGHTLIGHT is the national evaluation of TYA cancer services to examine outcomes associated with differing places and levels of care. We aimed to examine the association between exposure to TYA-PTC care, survival and documentation of clinical processes of care. Design Prospective cohort study. Setting 109 National Health Service (NHS) hospitals across England. Participants 1114 TYA, aged 13–24, newly diagnosed with cancer between 2012 and 2014. Intervention Participants were assigned a TYA-PTC category dependent on the proportion of care delivered in a TYA-PTC in the first year after diagnosis: all care in a TYA-PTC (ALL-TYA-PTC, n=270), no care in a TYA-PTC (NO-TYA-PTC, n=359), and some care in a TYA-PTC with additional care in a children’s/adult unit (SOME-TYA-PTC, n=419). Primary outcome Data were collected on documented processes indicative of age-appropriate care using clinical report forms, and survival through linkage to NHS databases. Results TYA receiving NO-TYA-PTC care were less likely to have documentation of molecular diagnosis, be reviewed by a children’s or TYA multidisciplinary team, be assessed by supportive care services or have a fertility discussion. There was no significant difference in survival according to category of care. There was weak evidence that the association between care category and survival differed by age (p=0.08) with higher HRs for those over 19 receiving ALL or SOME-TYA-PTC compared with NO-TYA-PTC. Conclusion TYA-PTC care was associated with better documentation of clinical processes associated with age-appropriate care but not improved survival.

[1]  F. Gibson,et al.  Longitudinal cohort study of the impact of specialist cancer services for teenagers and young adults on quality of life: outcomes from the BRIGHTLIGHT study , 2020, BMJ Open.

[2]  S. Gupta,et al.  Development of System Performance Indicators for Adolescent and Young Adult Cancer Care and Control in Canada. , 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  Rachel M. Taylor,et al.  Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in England , 2019, BMJ Open.

[4]  A. Ferrari,et al.  Models of Care—There Is More Than One Way to Deliver , 2018, Cancer journal.

[5]  F. Gibson,et al.  Conceptualizing age-appropriate care for teenagers and young adults with cancer: a qualitative mixed-methods study , 2018, Adolescent health, medicine and therapeutics.

[6]  A. Baruchel,et al.  Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children? , 2018, Blood.

[7]  A. Herbert,et al.  Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort , 2018, The Lancet. Child & adolescent health.

[8]  C. Kenten,et al.  Qualitative study to understand the barriers to recruiting young people with cancer to BRIGHTLIGHT: a national cohort study in England , 2017, BMJ Open.

[9]  A. Glaser,et al.  Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK , 2017, BMC Cancer.

[10]  F. Gibson,et al.  Multi-Professional Perspectives on Adolescent and Young Adult Oncology Across Europe: An e-Delphi Survey. , 2017, Journal of adolescent and young adult oncology.

[11]  O. Husson,et al.  Health-Related Quality of Life in Adolescent and Young Adult Patients With Cancer: A Longitudinal Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Barr Planning a Comprehensive Program in Adolescent and Young Adult Oncology-A Collision with Reality. , 2016, Journal of adolescent and young adult oncology.

[13]  Rachel M. Taylor,et al.  Mapping Adolescent Cancer Services: How Do Young People, Their Families, and Staff Describe Specialized Cancer Care in England? , 2016, Cancer nursing.

[14]  J. Whelan,et al.  Direct access to potential research participants for a cohort study using a confidentiality waiver included in UK National Health Service legal statutes , 2016, BMJ Open.

[15]  C. Anders,et al.  Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma , 2016, Cancer.

[16]  L. Ries,et al.  Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “nonmalignant/noninvasive” tumors , 2016, Cancer.

[17]  F. Gibson,et al.  Development and validation of the BRIGHTLIGHT Survey, a patient-reported experience measure for young people with cancer , 2015, Health and Quality of Life Outcomes.

[18]  J. Whelan,et al.  Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials. , 2014, The Lancet. Oncology.

[19]  L. Fern,et al.  Why can’t we improve the timeliness of cancer diagnosis in children, teenagers, and young adults? , 2013, BMJ.

[20]  F. Gibson,et al.  The Art of Age-Appropriate Care: Reflecting on a Conceptual Model of the Cancer Experience for Teenagers and Young Adults , 2013, Cancer nursing.

[21]  Amiram Gafni,et al.  Outcomes and metrics , 2011, Cancer.

[22]  S. Palmer,et al.  Sex, drugs, and rock 'n' roll: caring for adolescents and young adults with cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Babb,et al.  Classification and incidence of cancers in adolescents and young adults in England 1979–1997 , 2002, British Journal of Cancer.

[24]  C. Stiller,et al.  Centralised treatment, entry to trials and survival. , 1994, British Journal of Cancer.

[25]  C. Stiller Centralisation of treatment and survival rates for cancer. , 1988, Archives of disease in childhood.

[26]  J. Mathias,et al.  Program , 1970, 2021 Symposium on VLSI Technology.